中之島クロスラボ's Launch of a Regenerative Medicine Services Hub
First written in FY2024. 1 of 3 entries say "Advanced", first in FY2025-H1. Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025AchievedAnnual report
「Opened Nakanoshima Cross Lab at Nakanoshima Qross, the Future Medicine International Hub for industry-government-academia collaboration in regenerative medicine (Nakanoshima, Kita-ku, Osaka), as an information hub providing contract analysis and CPC facilities.」
Opened Nakanoshima Cross Lab and began operations as an information hub for contract analysis, CPC facility provision and regenerative medicine. - FY2025-H1AdvancedAnnual report
「Opened Nakanoshima Cross Lab at Nakanoshima Qross, the Future Medicine International Hub for industry-government-academia collaboration in regenerative medicine (Nakanoshima, Kita-ku, Osaka), as an information hub providing contract analysis and CPC (Cell Processing Center) facilities.」
Opened Nakanoshima Cross Lab and began operations as an information hub for contract analysis, CPC facility provision and regenerative medicine. - FY2024First statedAnnual report
「The company will establish Nakanoshima Cross Lab at Nakanoshima Qross, an international hub for future medicine in Kita-ku, Osaka, which houses organizations including the Kyoto University iPS Cell Research Foundation. Through contract services at the lab and application development services for regenerative medicine products, it will serve as a base for providing comprehensive services, including consulting for regenerative medicine facilities.」
The company outlined plans to establish Nakanoshima Cross Lab as a base for contract services related to regenerative medicine, product application development and consulting for regenerative medicine facilities.